| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |